Asli Aybike Dogan

Postdoctoral Researcher at Novo Nordisk

Asli Aybike Dogan is a highly skilled researcher specializing in bioengineering and health technology, currently serving as a Postdoctoral Researcher at Novo Nordisk, focusing on the development of metabolically functional 3D engineered human skeletal muscle tissue models for Type 2 diabetes. With a strong background in advanced bioprinting and biofabrication techniques, Asli has contributed to multiple research initiatives, including developing physiologically relevant in vitro barrier tissues during a PhD at the Technical University of Denmark, and enhancing communication processes as a Board Member with the Scandinavian Society for Biomaterials. Academic qualifications include a PhD in Health Technology and a Master's degree in Bioengineering from Ege University, complemented by various research roles and internships that have fostered expertise in tissue engineering, molecular analysis, and cell culture.

Location

Copenhagen, Denmark

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Novo Nordisk

378 followers

Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.


Industries

Headquarters

Bagsværd, Denmark

Employees

10,000+

Links